A detailed history of Eukles Asset Management transactions in Chemed Corp stock. As of the latest transaction made, Eukles Asset Management holds 6,557 shares of CHE stock, worth $3.43 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
6,557
Previous 6,685 1.91%
Holding current value
$3.43 Million
Previous $3.63 Million 8.63%
% of portfolio
1.61%
Previous 1.6%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$527.82 - $600.97 $67,560 - $76,924
-128 Reduced 1.91%
6,557 $3.94 Million
Q2 2024

Aug 01, 2024

SELL
$532.42 - $640.63 $32,477 - $39,078
-61 Reduced 0.9%
6,685 $3.63 Million
Q1 2024

May 13, 2024

BUY
$566.18 - $650.7 $56,617 - $65,070
100 Added 1.5%
6,746 $4.33 Million
Q4 2023

Jan 31, 2024

SELL
$502.71 - $593.0 $25,135 - $29,650
-50 Reduced 0.75%
6,646 $3.89 Million
Q3 2023

Oct 25, 2023

BUY
$499.76 - $566.64 $22,489 - $25,498
45 Added 0.68%
6,696 $3.48 Million
Q2 2023

Aug 01, 2023

SELL
$529.45 - $567.21 $12,177 - $13,045
-23 Reduced 0.34%
6,651 $3.6 Million
Q1 2023

Apr 28, 2023

SELL
$490.23 - $537.75 $41,669 - $45,708
-85 Reduced 1.26%
6,674 $3.59 Million
Q4 2022

Jan 27, 2023

SELL
$432.5 - $523.63 $128,020 - $154,994
-296 Reduced 4.2%
6,759 $3.45 Million
Q3 2022

Oct 28, 2022

SELL
$436.56 - $524.08 $55,879 - $67,082
-128 Reduced 1.78%
7,055 $3.08 Million
Q2 2022

Jul 28, 2022

SELL
$437.63 - $523.06 $6,126 - $7,322
-14 Reduced 0.19%
7,183 $3.37 Million
Q1 2022

Apr 27, 2022

SELL
$452.33 - $527.05 $73,729 - $85,909
-163 Reduced 2.21%
7,197 $3.65 Million
Q4 2021

Feb 10, 2022

BUY
$407.54 - $536.14 $29,750 - $39,138
73 Added 1.0%
7,360 $3.89 Million
Q3 2021

Oct 28, 2021

BUY
$451.98 - $485.71 $170,396 - $183,112
377 Added 5.46%
7,287 $3.39 Million
Q2 2021

Jul 27, 2021

BUY
$459.25 - $502.91 $111,138 - $121,704
242 Added 3.63%
6,910 $3.28 Million
Q1 2021

Apr 27, 2021

BUY
$420.53 - $556.02 $156,437 - $206,839
372 Added 5.91%
6,668 $3.07 Million
Q4 2020

Jan 26, 2021

BUY
$463.46 - $538.88 $22,246 - $25,866
48 Added 0.77%
6,296 $3.35 Million
Q3 2020

Oct 29, 2020

BUY
$455.52 - $523.47 $18,220 - $20,938
40 Added 0.64%
6,248 $3 Million
Q2 2020

Jul 29, 2020

BUY
$400.58 - $482.27 $81,718 - $98,383
204 Added 3.4%
6,208 $2.8 Million
Q1 2020

Apr 22, 2020

SELL
$351.57 - $507.2 $100,900 - $145,566
-287 Reduced 4.56%
6,004 $2.6 Million
Q4 2019

Jan 24, 2020

SELL
$393.91 - $441.41 $24,816 - $27,808
-63 Reduced 0.99%
6,291 $2.76 Million
Q3 2019

Oct 29, 2019

SELL
$364.54 - $439.82 $12,029 - $14,514
-33 Reduced 0.52%
6,354 $2.65 Million
Q2 2019

Aug 01, 2019

SELL
$316.8 - $360.84 $9,820 - $11,186
-31 Reduced 0.48%
6,387 $2.31 Million
Q1 2019

Apr 23, 2019

SELL
$265.79 - $331.76 $4,252 - $5,308
-16 Reduced 0.25%
6,418 $2.05 Million
Q4 2018

Jan 22, 2019

BUY
$266.56 - $324.23 $1.72 Million - $2.09 Million
6,434 New
6,434 $1.82 Million

Others Institutions Holding CHE

About CHEMED CORP


  • Ticker CHE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 14,904,900
  • Market Cap $7.8B
  • Description
  • Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, ...
More about CHE
Track This Portfolio

Track Eukles Asset Management Portfolio

Follow Eukles Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eukles Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Eukles Asset Management with notifications on news.